kana enomoto keynote
TRANSCRIPT
![Page 1: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/1.jpg)
1
![Page 2: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/2.jpg)
ADVANCING THE BEHAVIORAL HEALTH OF THE NATION:
AMERICA’S OPIOID CRISISKana Enomoto
Substance Abuse and Mental Health Services Administration
2016 National RX Drug Abuse & Heroin Summit Atlanta, GA • March 29, 2016
![Page 3: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/3.jpg)
3
NEONATAL ABSTINENCE SYNDROME
![Page 4: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/4.jpg)
4
![Page 5: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/5.jpg)
5
US death rates fell steadily until 1999
Case & Deaton. Rising morbidity and mortality in midlife among white Non-Hispanic Americans in the 21st century. PNAS [epub Nov 2, 2015].
Sweden
Australia
CanadaUK
USHispanics
Germany
France
US non-HispanicWhites
… but then began to increase
among middle-aged white Americans
Dea
ths
per 1
00,0
00 p
opul
atio
nag
es 4
5-54
OVERDOSE
![Page 6: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/6.jpg)
6
![Page 7: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/7.jpg)
7
OUR STRATEGY
1) Improving prescriber practices
2) Increasing the use of naloxone
3) Expanding access to MAT
![Page 8: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/8.jpg)
8
Improving Prescriber Practices
• NEW: SAMHSA SPF Rx Grants• $10,000,000• 20 States• PDMP data to prevent Rx Misuse
![Page 9: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/9.jpg)
9
INCREASING USE OF NALOXONE• NEW: SAMHSA
Prescription Drug Overdose Grants
• $12,000,000
• 10 States
• Purchase, Equip, Train
![Page 10: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/10.jpg)
10
NEW: Buprenorphine Notice of Proposed
Rulemaking
NEW: MAT Pocket Guide
EXPANDING ACCESS TO MAT
•NEW: SAMHSA Medication Assisted Treatment for Prescription Drug and Opioid Addiction (MAT-PDOA) Grants•$25,000,000•23 States•Focus on high-need communities
![Page 11: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/11.jpg)
11
OUR IMPACT
![Page 12: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/12.jpg)
12
Continuing education to over 72,000 primary care physicians, dentists, and other healthcare professionals
31,552 physicians with a waiver to prescribe buprenorphine for opioid dependence
Over 76,500 Downloads
OUR IMPACT
![Page 13: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/13.jpg)
13
PPW
OUR IMPACT
![Page 14: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/14.jpg)
14
OUR FUTURE
FY2017: $4.3B investment in SAMHSA +$590M
State Cooperative Agreements/Evaluation
Buprenorphine Prescribing Authority Demo
PPW Demo
![Page 15: Kana Enomoto keynote](https://reader036.vdocuments.pub/reader036/viewer/2022062412/5879acc11a28ab6b2c8b47dd/html5/thumbnails/15.jpg)
15